TD Cowen Sticks to Its Buy Rating for Gilead Sciences (GILD)
I'm PortAI, I can summarize articles.
TD Cowen analyst Tyler Van Buren has reaffirmed a Buy rating for Gilead Sciences (GILD) with a price target of $125.00, while the shares closed at $122.60. Van Buren, a 5-star analyst, has an average return of 20.1% and a 54.15% success rate. Additionally, Truist Financial also issued a Buy rating for Gilead, while RBC Capital maintained a Hold rating on January 8.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments